Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Roche Holding AG (OTCQX International Premier:RHHBY)

Delayed Data
As of Jul 22
 +0.13 / +0.41%
Today’s Change
Today|||52-Week Range
Siegfried Holdings, Held by Tweedy Browne, Way Undervalued
Jul 22 / GuruFocus News - Paid Partner Content
Amgen and Daiichi Sankyo Team Up for Biosimilars in Japan
Jul 14 / Zacks.com - Paid Partner Content
Biogen Should Either a Buyer or a Seller Be
Jul 22 / TheStreet.com - Paid Partner Content
5 Things Celldex Therapeutics, Inc. Wants You to Know
Jul 13 / MotleyFool.com - Paid Partner Content
Roche's Gazyva Fails in Phase III B-cell Lymphoma Study
Jul 18 / Zacks.com - Paid Partner Content
Pfizer (PFE) Gets FDA Nod for Label Expansion of Prevnar 13
Jul 13 / Zacks.com - Paid Partner Content
3 Stocks to Buy and Hold Forever
Jul 15 / MotleyFool.com - Paid Partner Content
Sucampo to Stop Developing Cobiprostone for Oral Mucositis
Jul 12 / Zacks.com - Paid Partner Content
Novartis' Enbrel Biosimilar Gets FDA Panel Recommendation
Jul 14 / Zacks.com - Paid Partner Content
Shire's (SHPG) Dry Eye Disease Drug Xiidra Gets FDA Nod
Jul 12 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close31.56
Today’s open31.80
Day’s range31.56 - 31.84
Average volume (3 months)986,025
Market cap$175.4B
Dividend yield3.21%
Data as of 3:58pm ET, 07/22/2016

Growth & Valuation

Earnings growth (last year)-9.78%
Earnings growth (this year)--
Earnings growth (next 5 years)+8.18%
Revenue growth (last year)-3.39%
P/E ratio--


No competitors data available.


Next reporting dateOctober 18, 2016
EPS forecast (this quarter)$0.92
Annual revenue (last year)$50.0B
Annual profit (last year)$9.2B
Net profit margin18.41%


Health Technology
Pharmaceuticals: Major
Chief Executive Officer &
Executive Director
Severin Schwan
Roche Diagnostics Division
Roland Diggelmann
Corporate headquarters
Basel, Basel-stadt (basle Town)


Partner Offers

Search for Jobs